Senate Resolution 114 recognizes June 2025 as “Migraine and Headache Awareness Month” in Pennsylvania. The resolution is largely commemorative and educational: it highlights the prevalence and seriousness of headache disorders, including migraine, cluster headache, new daily persistent headache, spinal CSF leak, and other neurological headache diseases. It emphasizes that these conditions affect millions of people, can be disabling, and often involve symptoms beyond head pain, such as vision problems, cognitive impairment, balance issues, and reduced ability to carry out daily activities.
The resolution also frames headache disorders as a public health and equity issue. It notes disparities in diagnosis and treatment affecting women, veterans, children, and historically marginalized communities, and it points to limited access to specialists, especially in rural and underserved areas. The text further stresses the economic burden of headache disorders, the stigma surrounding them, and the need for research, improved treatment options, and mental health support.
In terms of legal impact, SR114 does not change Pennsylvania statutes, create new regulatory requirements, or appropriate funds. Its effect is symbolic and promotional: it formally designates June 2025 as an awareness month and encourages citizens, healthcare professionals, and policymakers to support education, research, and better access to care for headache diseases. Because it is a resolution, it operates as a statement of legislative recognition rather than a binding law.
The general sentiment around the resolution is strongly supportive and sympathetic toward people living with migraine and other headache disorders. The bill’s findings present these conditions as underrecognized, underdiagnosed, and undertreated, and the resolution is framed as a call for greater public awareness and improved care. No committee debate or recorded votes are provided, so there is no evidence of opposition in the available record.
The main points of emphasis are the need for equitable access to treatment, the shortage of headache specialists, and the disproportionate impact on women, veterans, children, and Black, Hispanic, Native, and Indigenous communities. The resolution also highlights the connection between headache disorders and depression or suicidal ideation, suggesting that comprehensive medical and mental health support is a key concern.
SR114 has no direct effect on Pennsylvania statutory law, administrative rules, or state spending. It is a nonbinding Senate resolution that formally recognizes June 2025 as Migraine and Headache Awareness Month and encourages awareness, research, and improved access to care. Its practical impact is limited to public recognition and advocacy, though it may help elevate attention to headache disorders among policymakers, healthcare providers, and the public.
The available text reflects a strongly favorable and compassionate sentiment toward the resolution. The Senate’s findings portray migraine and other headache disorders as serious, widespread, and often misunderstood conditions that deserve greater attention, research, and treatment access. No votes or committee transcripts are available, but nothing in the record suggests controversy or organized opposition.
No formal contention is shown in the available materials, and there are no recorded votes or committee remarks to indicate disagreement. The resolution’s most notable policy concerns are the shortage of headache specialists, disparities in diagnosis and treatment for marginalized communities, and the need for better access to affordable care. If any disagreement existed, it would most likely relate to the resolution’s emphasis on public awareness rather than any binding policy change, but no such opposition is documented here.